Currents in contemporary ethics
Currents in contemporary ethics
复制标题
DOI：
10.1111/j.1748-720x.2002.tb00726.x
复制
发表时间：
2002-03-01
影响因子：
2.1
通讯作者：
Rothstein, MA
中科院分区：
文献类型：
--
作者：
Rothstein, MA
在生物医学研究的后基因组世界中，一个越来越普遍的研究策略是专注于大型生物标本库。现在有几个众所周知的努力，汇编大量的生物材料，重新分析现存的样本，收集新的，并将样本与医疗记录联系起来。当商业企业在收集和分发样本方面发挥主导作用时，这些研究活动提出的法律、道德和政策等重大问题通常会得到加强。新兴公司不仅在为自己的使用汇编知识库，而且一些公司正在将自己定位为中介，开发庞大的生物库，销售给其他广泛的研究人员。
In the post-genome world of biomedical research, an increasingly common research strategy is to focus on large repositories of biological specimens. There are now several well-known efforts to compile vast collections of biological materials, reanalyze extant samples, collect new ones, and link the samples to medical records. The significant issues of law, ethics, and policy raised by these research activities usually are heightened when commercial enterprises play a leading role in accumulating and distributing the samples. Emerging companies are not only compiling repositories for their own use, but some companies are positioning themselves to act as intermediaries, developing vast biobanks for sale to a wide range of other researchers.